Details of the Drug

General Information of Drug (ID: DMCUNZL)

• Drug Name: E2023
• Synonyms: Lorcaserin

Indication

Disease Entry	ICD 11	Status	REF
Dravet syndrome	8A61.11	Phase 3	[1]

• ATC Code:
  A08AA11: E2023
  A08AA: Centrally acting antiobesity products
  A08A: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
  A08: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
  A: ALIMENTARY TRACT AND METABOLISM
• Drug Type: Small molecule
• Cross-matching ID: TTD ID: D3SJB9

References

• [1] ClinicalTrials.gov (NCT04572243) A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome. U.S.National Institutes of Health.